2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Lung Neoplasms
3
Neoplasms
2
Motor Activity
2
Breast Neoplasms
2
Anxiety Disorders
2
Stress Disorders, Post-Traumatic
1
Social Stigma
1
Prostatic Neoplasms
1
Noonan Syndrome
1
Neurofibromatosis 1
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Acute
1
Legius syndrome
1
Hematologic Neoplasms
1
Genetic Diseases, Inborn
1
Generalized Anxiety Disorder
1
Fatigue
1
Disease
1
Depression
1
Costello Syndrome
1
Chronic Pain
1
Cardiofaciocutaneous syndrome
1
Breast Cancer With Chronic Lymphedema
1
Breast Cancer Female
1
Interventions
Docetaxel
292
Prednisone
241
enzalutamide
195
Leuprolide
185
Radiotherapy
179
Abiraterone Acetate
170
Magnetic Resonance Spectroscopy
163
bicalutamide
141
Goserelin
138
Androgen Antagonists
121
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
108
Radiosurgery
108
apalutamide
93
abiraterone
83
gallium 68 PSMA-11
81
Specimen Handling
73
darolutamide
67
Surveys and Questionnaires
64
Gonadotropin-Releasing Hormone
63
Triptorelin Pamoate
58
Radiation
57
Biopsy
57
Brachytherapy
54
cabazitaxel
53
Standard of Care
51
Radiotherapy, Intensity-Modulated
51
Zoledronic Acid
50
pembrolizumab
49
luprolide acetate gel depot
49
Flutamide
47
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Waiting Lists
×
Clear all
NCT07620717
2026-06-02
PROCAN-B+
University of Sunderland
Phase NA
Not yet recruiting
300 enrolled